Readiness, Education, and Sustainability for CGM Technology Adoption Model for Older Adults With Insulin-treated Diabetes
Sponsor: Joslin Diabetes Center
Trial Details
| Condition | Diabetes Mellitus |
| Intervention | Continuous Glucose Monitor |
| Phase | NA |
| Status | Active |
| Participants | 122 |
| Est. Completion | 11 Nov 2025 |
| Last Updated | 17 Apr 2026 |
Primary Outcome
The co-primary effectiveness outcomes; The co-primary implementation outcomes
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Older adults age ≥65 years * T1D or T2D with duration longer than 1 year * Insulin treatment includes: ≥3 insulin injections/day or on insulin pump therapy * CGM naïve and/or CGM users (Dexcom G6) who are not meeting glycemic goals (per CGM metrics): * ≥4% hypoglycemia (sensor glucose ≤70 mg/dL) or * time in range (70-180 mg/dL) TIR ≤40 % * Willing to wear CGM Dexcom at all times while in the study * Willing to use/carry personal or loaned smart phone device to use as Dexcom receiver for continual data upload to cloud Exclusion Criteria: * Life expectancy \<1 year * End-stage renal disease (eGFR\< 30ml/min) * On acetaminophen \>4 gr/day due to interference with Dexcom G6 sensor readings * On hydroxyurea therapy due to interference with Dexcom G6 sensor readings * Impaired vision and hearing which would interfere with participation in remote video visits * Use of hybrid closed-loop systems (this may require different and additional focused education and will not be addressed in this study).
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service